AV Access Study to be Presented at the Vascular Annual Meeting (VAM25)DURHAM, N.C., June 02, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company ...

Akebia continues to publish important, clinically relevant data to further physicians’ understanding of Vafseo® ...

A major international study presented at the 62nd ERA Congress reveals that the long-accepted survival advantage of ...

The proposed nomogram demonstrated strong predictive accuracy and clinical usefulness, offering a valuable tool for early ...

Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, presents new research and innovations at the 62nd Congress of the European ...

A major international study, being presented today at the 62nd ERA Congress, reveals that the long-accepted survival ...

New data from the CONFIDENCE trial demonstrates that combination therapy with finerenone and empagliflozin leads to ...

Surgeons from Keck Medicine of USC and UCLA Health have performed the world's first-in-human bladder transplant.

ASX health stocks have fallen in the week ending June 6, but Morgans says the market is looking fairly positive at the year's ...

PKD is a genetic disorder marked by kidney cysts and progressive damage. Discover the science, treatment guidelines, and ...

Hyporesponsiveness to erythropoiesis-stimulating agents (ESAs), whether defined as lack of hemoglobin response to typical ESA doses or need for higher ESA doses to reach hemoglobi ...